Daly Richard J bought 26,825 shares of Aquestive Therapeutics, Inc. at $3.55 for $95.1k on Nov 10, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$95,094.63Shares × reported price
Shares traded
26,825Common Stock
Price per share
$3.55Reported price. Read footnotes for ranges.
% of reported position traded
2,235.42%This security and ownership context
Holdings after
28,025Direct
Trade date
Nov 10, 2026Buy
Filed
Nov 12, 2026, 11:59 AM ET2-day reporting delay
Accession
0001214659-26-014004Code P · Transaction 398500
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 1,200 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Buy1,200$3.53$4,236Trade 398499
2 transaction rows in this filing. Joint filers share the same rows.

AQST price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
AQST · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +34%1w ago +8.4%1d ago −1.1%
Returns since7d30d90d180d1y

Footnotes in full

F1: The reported shares were purchased by the Reporting Person in open market transactions.